Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68 | 249 | 353 | 61 | 111 |
| Receivables | 124 | 63 | 257 | 251 | 213 |
| TOTAL | $239 | $373 | $718 | $474 | $519 |
| Non-Current Assets | |||||
| PPE Net | 138 | 153 | 169 | 184 | 199 |
| TOTAL | $138 | $153 | $169 | $184 | $199 |
| Total Assets | $377 | $527 | $886 | $658 | $718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,136 | 1,982 | 1,871 | 1,357 | 63 |
| Accounts payable and accrued liabilities | 2,198 | 1,815 | 1,926 | 1,700 | 1,601 |
| Accrued Expenses | 465 | 534 | 356 | 295 | 127 |
| TOTAL | $4,894 | $4,411 | $4,231 | $3,427 | $1,864 |
| Non-Current Liabilities | |||||
| Long Term Debt | 42 | 48 | 53 | 59 | 1,145 |
| Deferred Revenues | 23 | 10 | 10 | 10 | 10 |
| TOTAL | $141 | $166 | $189 | $212 | $1,316 |
| Total Liabilities | $5,035 | $4,577 | $4,421 | $3,640 | $3,179 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 167,704 | N/A | N/A | N/A | N/A |
| Common Shares | 44,614 | 44,483 | 43,964 | 43,777 | 43,236 |
| Retained earnings | -61,413 | -60,661 | -59,372 | -58,413 | -57,353 |
| Other shareholders' equity | 64 | 96 | 46 | 45 | 82 |
| TOTAL | $-4,657 | $-4,050 | $-3,534 | $-2,982 | $-2,461 |
| Total Liabilities And Equity | $377 | $527 | $886 | $658 | $718 |